返回 
加入收藏
CMDS软件初筛结合人工审核模式在我院中成药处方点评中的应用实践
x
请在关注微信后，向客服人员索取文件
| 篇名： | CMDS软件初筛结合人工审核模式在我院中成药处方点评中的应用实践 |
| TITLE： | |
| 摘要： | 目的：探索临床用药决策支持软件（CMDS）初筛结合药师人工审核的中成药处方点评模式，提高中成药临床应用安全性。方法：利用CMDS软件对我院2017年3月11－20日的11 780张中成药处方进行合理性初步筛查，再由处方点评小组药师对软件发送的提示信息进行人工审核，判定不合理用药结果并对不合理用药提示信息进行分级调整。结果：CMDS软件对2 411张中成药处方发送了3 560条不合理用药提示信息。经药师审核后判定，不合理用药处方共279张，不合理率为2.37％；其中92张处方的不合理用药提示信息被人工上调为“重要提示”级别。结论：我院中成药电子处方基本合理，然而也存在禁忌证用药、重复用药等问题。目前，信息化技术用于中成药处方合理性审核仍处于初期摸索阶段，筛查结果仍不够准确，无效提醒较多，还需要药师结合临床实际情况人工审核后判定。随着软件升级及优化，CMDS软件初筛辅助药师人工审核将成为今后中成药处方点评的重要模式。 |
| ABSTRACT： | OBJECTIVE： To explore the prescription evaluation mode of Clinical Medication Decision Support （CMDS） software screening combined with manual review， and to improve the safety of clinical use of Chinese patent medicine. METHODS： CMDS software was used to primarily screen the rationality of Chinese patent medicine prescription in our hospital during Mar. 11th-20th 2017. The information sent by the software was manually checked by the pharmacists of the prescription review team. The results of irrational drug use were determined and grading was adjusted. RESULTS： CMDS software sent 3 560 tips of irrational drug use for 2 411 Chinese patent medicine prescriptions. After pharmacist review， there were 279 irrational prescriptions， with irrational rate of 2.37％. Among them， irrational drug use of 92 prescriptions was manually adjusted as “important tips”. CONCLUSIONS： The prescription of Chinese patent medicine in our hospital is generally reasonable. However，there still are contraindications， repeated medication and other issues. Currently， the application of information technology in prescription rationality screening for Chinese patent medicine is still at its early stage of exploration. The evaluation results are still not accurate enough， and there are many invalid reminders. The prescriptions should be reviewed by pharmacists based on practice. With the upgrading and optimization of software， the initial screening of CMDS software combined with manual review of pharmacists will become an important mode for the evaluation of Chinese patent medicines. |
| 期刊： | 2018年第29卷第16期 |
| 作者： | 沈剑文，闫晶超，陆琦枫，陈念祖 |
| AUTHORS： | SHEN Jianwen，YAN Jingchao，LU Qifeng，CHEN Nianzu |
| 关键字： | 中成药；临床用药决策支持软件；人工审核；处方点评 |
| KEYWORDS： | Chinese patent medicine； Clinical Medication Decision Support Software； Manual review； Prescription evaluation |
| 阅读数： | 358 次 |
| 本月下载数： | 4 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
